Medicare Enrolled
Dr. Richard Sims, MD
Interventional Pain Medicine Physician · Daytona Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sims from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sims?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sims
Dr. Richard Sims is an interventional pain medicine physician in Daytona Beach, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Sims performed 4,949 Medicare services across 2,792 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sims received a total of $6,632 from 15 pharmaceutical and/or device companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sims is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 30% volume in FL
$6,632 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 136714 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗4,949
Medicare services
Top 30% in FL for interventional pain medicine physician
2,792
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~412 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,080 | $19 | $64 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
753 | $69 | $274 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
686 | $94 | $389 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
383 | $123 | $507 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
240 | $106 | $1,143 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
200 | $79 | $732 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
169 | $37 | $148 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
155 | $106 | $1,048 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
148 | $61 | $543 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
142 | $21 | $82 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
114 | $1 | $4 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
104 | $224 | $2,441 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
98 | $71 | $1,014 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
91 | $12 | $38 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
67 | $114 | $998 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
61 | $65 | $508 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
54 | $151 | $1,276 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
51 | $54 | $572 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
44 | $55 | $210 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $45 | $167 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
32 | $41 | $154 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
30 | $44 | $188 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
28 | $79 | $792 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
26 | $86 | $805 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $6 | $17 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
19 | $40 | $335 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
19 | $26 | $96 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
18 | $776 | $3,408 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $11 | $42 |
| Nerve destruction for spine-pelvis joint pain A procedure that destroys the nerves supplying the joint between the spine and pelvis to relieve pain. Imaging guidance is used to ensure accurate placement. |
15 | $163 | $1,895 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 12 | $367 | $1,395 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
12 | $25 | $115 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
11 | $26 | $116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,632
Total received (2019-2024)
Avg $1,105/year across 6 years
Top 35% in FL for interventional pain medicine physician
15
Companies
105
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,632 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$352
2023
$1,576
2022
$270
2021
$470
2020
$373
2019
$3,591
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$2,500
Vertiflex, Inc.
$1,179
Boston Scientific Corporation
$914
Relievant Medsystems, Inc.
$807
Medtronic, Inc.
$355
BOSTON SCIENTIFIC CORPORATION
$313
Nutech Spine, Inc.
$198
Vertos Medical, Inc.
$186
Nevro Corp.
$48
SI-BONE, Inc.
$45
Stimwave Technologies Incorporated
$22
Pacira Pharmaceuticals Incorporated
$19
Embody, Inc.
$18
SI-BONE, INC.
$16
Nalu Medical, Inc.
$13
Top 3 companies account for 69.2% of total payments
Associated products mentioned in payments ›
Cardiovascular- Research only · ETERNA · GENERAL PAIN MANAGEMENT · IFUSE IMPLANT · INTELLIS ADAPTIVESTIM · Intracept · Iovera · NA · NT1100 NT2000iX Simplicity · Nalu Neurostimulation System · Octrode SCS Leads · PENTA · Proclaim Family of SCS IPGs · Proclaim IPG · S-Series SCS Leads · SPECTRA WAVEWRITER · SUPERION · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · VERTIFLEX SUPERION · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $134 per 100 Medicare services performed
Geographic Context
Interventional pain medicine physicians within 10 mi
4
Per 100K population
0.7
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sims is a clinical cardiology specialist, with above-average Medicare volume (top 30% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sims experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sims performed 1,080 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sims receive payments from pharmaceutical companies?
Yes. Dr. Sims received a total of $6,632 from 15 companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sims's costs compare to other interventional pain medicine physicians in Daytona Beach?
Dr. Sims's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sims) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Daytona Beach
Browse interventional pain medicine physicians in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in FL
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in FL
Which FL interventional pain medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Vertiflex, Inc. Payments to Doctors
See all physicians who received payments from Vertiflex, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology